TIDES USA 2026: Oligonucleotide and Peptide Therapeutics
Date: 11-14 May 2026 Venue: Hynes Convention Center, Boston, MA
2026-04-30
Date: 13-15 May 2026 Venue: National Exhibition and Convention Center(Shanghai)
2026-04-30
Topical Formulation Services Accelerate Innovation in Dermatology and Drug Delivery
The pharmaceutical sector is experiencing rapid growth in Topical Formulation Services, driven by increasing demand for targeted, non-invasive therapies. As dermatology pipelines expand and new delivery technologies emerge, Topical Formulation Services are becoming essential for translating complex molecules into safe, effective treatments for patients worldwide.
2026-04-30
GMP Small Molecule Manufacturing Enters a New Era of Innovation and Expansion
The global pharmaceutical industry is witnessing rapid transformation as GMP small molecule manufacturing continues to evolve alongside new therapeutic demands. With small molecules still accounting for a significant share of approved drugs, the importance of GMP small molecule production remains central to ensuring safety, quality, and scalability in modern drug development.
2026-04-23
Peptide API Manufacturing Enters a New Era of Innovation and Global Expansion
The global pharmaceutical industry is witnessing a significant transformation driven by advances in Peptide API Manufacturing. As peptide-based therapeutics gain traction in treating chronic diseases such as diabetes, obesity, and cancer, demand for high-quality peptide active pharmaceutical ingredients continues to surge. This trend is reshaping the landscape of Peptide API Manufacturing, pushing contract development and manufacturing organizations (CDMOs) to innovate and scale rapidly to handle this increasing demand.
2026-04-16
Topical Formulation CDMO Gains Momentum as Demand for Advanced Drug Delivery Surges
The global pharmaceutical outsourcing landscape is witnessing rapid transformation, with Topical Formulation CDMO services emerging as a key growth engine. As demand for dermatological and localized therapies continues to rise, Topical Formulation CDMO providers are playing an increasingly strategic role in accelerating drug development and commercialization.
2026-04-09
Date: 28–30 April 2026 Venue: COEX Convention & Exhibition Center, Seoul, South Korea
2026-04-02
2026-05-14
2026-04-23
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
Established Business Services（API）
Tel: 86-576-88881561
E-mail: bd@jiuzhoupharma.com
